Business Description
Ypsomed Holding AG
NAICS : 339112
SIC : 3841
ISIN : CH0019396990
Share Class Description:
FRA:OWX: Ordinary SharesDescription
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | 1.59 | |||||
Interest Coverage | 17.9 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 8.52 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8 | |||||
3-Year EBITDA Growth Rate | 32.9 | |||||
3-Year EPS without NRI Growth Rate | 191.8 | |||||
3-Year FCF Growth Rate | 10 | |||||
3-Year Book Growth Rate | 13.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 40.35 | |||||
Future 3-5Y Total Revenue Growth Rate | 22.7 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.77 | |||||
Quick Ratio | 0.6 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 68.55 | |||||
Days Sales Outstanding | 70.33 | |||||
Days Payable | 25.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.73 | |||||
3-Year Dividend Growth Rate | 114 | |||||
3-Year Average Share Buyback Ratio | -2.5 | |||||
Shareholder Yield % | -1.25 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.47 | |||||
Operating Margin % | 15.72 | |||||
Net Margin % | 14.29 | |||||
FCF Margin % | -5.85 | |||||
ROE % | 13.41 | |||||
ROA % | 8.11 | |||||
ROIC % | 8.24 | |||||
ROC (Joel Greenblatt) % | 19.3 | |||||
ROCE % | 13.84 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 73.52 | |||||
PE Ratio without NRI | 73.52 | |||||
Shiller PE Ratio | 136.04 | |||||
Price-to-Owner-Earnings | 144.62 | |||||
PEG Ratio | 6.18 | |||||
PS Ratio | 10.5 | |||||
PB Ratio | 9.32 | |||||
Price-to-Tangible-Book | 17.13 | |||||
Price-to-Operating-Cash-Flow | 35.29 | |||||
EV-to-EBIT | 68.55 | |||||
EV-to-EBITDA | 36.78 | |||||
EV-to-Revenue | 10.83 | |||||
EV-to-FCF | -185.18 | |||||
Price-to-Projected-FCF | 80.99 | |||||
Price-to-DCF (Earnings Based) | 4.56 | |||||
Price-to-Median-PS-Value | 2.26 | |||||
Price-to-Peter-Lynch-Fair-Value | 6.17 | |||||
Price-to-Graham-Number | 7.48 | |||||
Earnings Yield (Greenblatt) % | 1.46 | |||||
FCF Yield % | -0.56 | |||||
Forward Rate of Return (Yacktman) % | 11.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ypsomed Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 569.431 | ||
EPS (TTM) (€) | 2.791 | ||
Beta | 0 | ||
Volatility % | 1.19 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 120.372 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 120.372 - 120.372 | ||
Shares Outstanding (Mil) | 13.65 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ypsomed Holding AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ypsomed Holding AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ypsomed Holding AG Frequently Asked Questions
What is Ypsomed Holding AG(FRA:OWX)'s stock price today?
The current price of FRA:OWX is €120.37. The 52 week high of FRA:OWX is €120.37 and 52 week low is €120.37.
When is next earnings date of Ypsomed Holding AG(FRA:OWX)?
The next earnings date of Ypsomed Holding AG(FRA:OWX) is .
Does Ypsomed Holding AG(FRA:OWX) pay dividends? If so, how much?
Ypsomed Holding AG(FRA:OWX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |